Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Nov 27, 2019
Our Chief Executive Officer, Dr James Garner, recently sat down with Stuart Roberts of Pitt Street Research in Sydney to discuss the company’s recent announcement of positive interim efficacy data from its phase II trial of GDC-0084 in glioblastoma.